Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FX3ZZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,849
Award facts
- Contract value 100% obligated
- $61,848.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $61,848.91 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL). This firm fixed price, competitively awarded contract carries an ultimate completion date of October 29, 2025, and involves delivery to AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating open competition among qualified vendors. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis and other allergic and inflammatory conditions, representing a critical pharmaceutical commodity for military healthcare systems.
This delivery order is issued against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime vendor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. The company's established track record of successfully managing multiple pharmaceutical delivery orders with consistent firm fixed pricing demonstrates its capability to meet federal medical procurement requirements efficiently.
Quick answers
Who was awarded contract SPE2DB26FX3ZZ?
SPE2DB26FX3ZZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FX3ZZ worth?
The government has obligated $61,849 on SPE2DB26FX3ZZ.
Is contract SPE2DB26FX3ZZ an order under another contract?
Yes. SPE2DB26FX3ZZ is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3ZZ competed?
The extent of competition for SPE2DB26FX3ZZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award